Enhancement of muscle flap hemodynamics by Angiopoietin-1

Annals of Plastic Surgery

Volumn 48, Issue 4, 2002, Pages 401-409

  Gurunluoglu, Raffi ^a   Lubiatowski, Przemyslaw ^a   Goldman, Corey K ^a   Carnevale, Kevin ^a   Siemionow, Maria ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; GREEN FLUORESCENT PROTEIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CAPILLARY DENSITY; CAPILLARY PERMEABILITY; CONTROLLED STUDY; CREMASTER MUSCLE; FLUORESCENCE MICROSCOPY; HEMODYNAMICS; HISTOLOGY; MALE; MUSCLE FLAP; NONHUMAN; PRIORITY JOURNAL; RAT; VIRAL GENE DELIVERY SYSTEM;

EID: 0036204002     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000637-200204000-00011     Document Type: Article

References (29)

1. Mechanisms of angiogenesis
2. Isolation of angiopoietin-1, a ligand for the TIE2 receptor by secretion-trap expression cloning
3. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
4. Dominant negative and targeted null mutations in the endothelial receptor tyrosine kinase, Tek, reveal a critical role in vasculogenesis of the embryo
5. Requisite role of angiopoietin-1, a ligand for the Tie-2 receptor, during embryonic angiogenesis
6. Angiopoietin-1 protects the adult vasculature against plasma leakage
7. Leaky vessels? Call Ang-1
8. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1
9. Vascular isolation of the rat cremaster muscle
10. Direct in vivo observation of embolic events in the microcirculation distal to a small-vessel anastomosis
11. Effect of muscle flap denervation on flow hemodynamics: A new model for chronic in vivo studies
12. Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion
13. Adenovirus-mediated gene transfer to lower limb artery of patients with chronic critical leg ischemia
14. Adenovirus-mediated gene transfer into normal arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia
15. VEGF gene delivery to myocardium: Deleterious effects of unregulated expression
16. Cardiovascular gene therapy
17. Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121
18. Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb
19. Tie2 receptor ligands, angiopoietin-1 and angiopoietin-2, modulate VEGF-induced postnatal neovascularization
20. Molecular cloning, expression, and characterization of angiopoietin-related protein. Angiopoietin-related protein induces endothelial cell sprouting
21. Angiopoietin-1 induces sprouting angiogenesis in vitro
22. Chemotactic properties of angiopoietin-1 and 2, ligands for the endothelial-specific receptor tyrosine kinase Tie2
23. TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth
24. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues
25. Improved perfusion after subcritical ischemia in muscle flaps treated with vascular endothelial growth factor
26. Effect of vascular endothelial growth factor (VEGF) on survival of random extension of axial pattern skin flaps in the rat
27. Locally administered vascular endothelial growth factor cDNA increases survival of ischemic experimental skin flaps
28. Clinical applications of angiogenic growth factors and their inhibitors
29. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor